Adjuvant therapy for high-risk medulloblastoma: more is better?

Neuro Oncol. 2021 Jul 1;23(7):1048-1049. doi: 10.1093/neuonc/noab104.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cerebellar Neoplasms* / therapy
  • Combined Modality Therapy
  • Humans
  • Medulloblastoma* / epidemiology
  • Medulloblastoma* / therapy